🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Mitomycin C

    AEON Biopharma

    Glaucoma

    phase 2 small molecule completed

    1 trial

  2. Mixed-Amphetamine Salts- Extended Release (MAS-ER)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  3. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    2 trials

  4. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule active

    2 trials

  5. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    3 trials

  6. Modafinil 0 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  7. Modafinil 200mg

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 2 small molecule terminated

    1 trial

  8. Monitoring and Feedback Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  9. Mood Management Phone Counseling for Smoking Cessation

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 other completed

    1 trial

  10. Mosunetuzumab

    Adaptive Biotechnologies Corp

    Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 2 small molecule active

    1 trial

  11. Motivational enhancement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Abuse

    phase 2 other completed

    1 trial

  12. Motivational interviewing

    BRIGHT MINDS BIOSCIENCES INC.

    Adherence

    phase 2 other active

    1 trial

  13. Moxifloxacin (M)

    BRIGHT MINDS BIOSCIENCES INC.

    Pulmonary Tuberculosis

    phase 2 small molecule completed

    1 trial

  14. Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 2 small molecule completed

    1 trial

  15. Multimedia WORTH

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  16. Myocet (Non-pegylated liposomal doxorubicin (NPLD))

    Sana Biotechnology

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  17. N Acetyl Cysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Gambling

    phase 2 small molecule completed

    1 trial

  18. N-Acetylcysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  19. N-acetylcysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  20. N-acetylcysteine (NAC)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  21. NAP (Naptumomab estafenatox)

    BRIGHT MINDS BIOSCIENCES INC.

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  22. NBI-1065890

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    phase 2 small molecule active

    1 trial

  23. NBI-1070770

    NEUROCRINE BIOSCIENCES INC

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial

  24. NBI-1117568

    NEUROCRINE BIOSCIENCES INC

    Bipolar I Disorder

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources